RoosterBio At ASGCT-2023: Confidently Crowing In A Crowd Of CRISPRs, Capsids, & CARs
Source: RoosterBio
By Mary Doolin, Jonathan Carson, & Joseph Candiello
This year at the ASGCT-2023 in Los Angeles, RoosterBio proudly displayed extracellular vesicles (EVs) and exosomes and showcased their capabilities. Cell and gene therapy, despite the vast promise, remain largely untapped for most of us until there are more regulatory approvals, and until radical efficiencies are incorporated into its supply chains. Explore the highlights of ASGCT-2023 and how RoosterBio uniquely contributed knowledge related to EVs and/or exosomes that benefitted those in attendance.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
RoosterBio
This website uses cookies to ensure you get the best experience on our website. Learn more